Osteoarthritis (OA) is a degenerative multifactorial disease with concomitant structural,
inflammatory, and metabolic changes that fluctuate in a temporal and patient-specific …

Cell therapy has been explored as a new regenerative treatment for osteoarthritis in the field
of regenerative medicine. However, the efficacy of stem cell transplantation from different …

Human articular cartilage has a poor ability to self‐repair, meaning small injuries often lead
to osteoarthritis, a painful and debilitating condition which is a major contributor to the global …

Osteoarthritis (OA) is a widespread osteoarticular pathology characterized by progressive
hyaline cartilage degradation, exposing horses to impaired well-being, premature career …

Among the available therapeutics for the conservative treatment of osteoarthritis (OA),
mesenchymal stromal cells (MSCs)-based products appear to be the most promising …

Osteoarthritis (OA) is a kind of degenerative joint disease usually found in older adults and
those who have received meniscal surgery, bringing great suffering to a number of patients …

Bone-marrow-derived mesenchymal stromal cells (BMSCs) showed therapeutic potential in
the treatment of musculoskeletal diseases, including osteoarthritis (OA). Their soluble …

Osteoarthritis (OA) is described as a chronic degenerative disease characterized by the loss
of articular cartilage. Senescence is a natural cellular response to stressors. Beneficial in …

Background: Clinical trials are currently underway to investigate the efficacy of intra-articular
administration of mesenchymal stromal cells (MSCs) to mitigate osteoarthritis (OA) …

Osteoarthritis affects 15% of people over 65 years of age. It is characterized by articular
cartilage degradation and inflammation, leading to joint pain and disability. Osteoarthritis is …